Isabella Martire, MD, Board Certified In Oncology
Isabella C. Martire, MD, AC
8343 Cherry Lane
Laurel, MD 20707
(301) 498-5067
Articles by this Professional:
- Stage III Melanoma
- Adjuvant Treatment For Stage III Melanoma
- Agents For Triple Negative Breast Cancer
- Microsatellite Instability
- Relapsed Or Refractory Chronic Lymphocytic Leukemia: Treatment Options
- Targeted Therapy For Renal Cell Cancer
- Pulmonary Toxicity From Check Point Inhibitors
- Local Therapy For Colorectal Liver Metastases
- Stage III Non-Small Cell Lung Cancer
- Check Point Inhibitor Side Effects
- BTK Bruton Tyrosine Kinase Inhibitors
- Consolidation Therapy For Stage III Non-Small Cell Lung Cancer
- Proteasome Inhibitors In Multiple Myeloma
- New Treatment For Indolent Lymphoma
- Novel Treatment BRCA Mutated Metastatic Breast Cancer
- Immunotherapy In Bladder Cancer
- Inhibitors CDK4 and CDK6 For Metastatic Breast Cancer
- Hormone Receptor Positive Breast Cancer
- Metastatic Bladder Cancer New Systemic Treatments
- Molecular Testing In Lung Cancer
- Oncology Has a New Class Of Drug
- HER2 Positive Metastatic Breast Cancer
- Immunotherapy For Small Cell Lung Cancer
- Bone Protective Therapy in Breast Cancer Patients
- Breast Cancer Subtypes
- Metastatic Renal Cell Cancer Therapeutic Options
- Metastatic NSCL Cancer Advances
- Chemotherapy Nausea and Vomiting Relief
- Metastatic Thyroid Cancer
- FDA Approved Multiple Myeloma Drugs
- Metastatic Melanoma New Targeted Therapies
- Immune Checkpoint Inhibitors
- Targeted Therapy For CLL
- New Treatments For Relapsed Myeloma
- Stopping the Growth and Spread Of Cancers
- Metastatic Castration Resistant Prostate Cancer
- The Top Advances In Oncology In the Last 50 Years
- Procrit The Facts
- HPV-Induced Oropharingeal Cancer
- Targeted Therapies Stage IV Melanoma
- Unresectable Non-Small Cell Lung Cancer
- Male Breast Cancer
- Treatments For Mantle Cell Lymphoma
- Advanced Non Small Cell Lung Cancer
- Targeted Therapies For Colorectal Cancer
- Breast Cancer What's New In 2013?
- Melanoma Update
- The Oncology Setting That Fits Your Needs
- Esophageal Cancer In 2013
- Vaccine Therapy For Solid Tumors
- New NCCN Guidelines For Cancer Survivors
- Colorectal Cancer Prevention and Screening
- Cancer Drugs Approved In 2012 Part Two
- Cancer Drugs Approved In 2012
- Head and Neck Cancer Molecular Targeted Therapy
- Treatment Options For Hepatocellular Carcinoma
- Thyroid Cancer
- HER2-neu Positive Breast Cancer Available Therapies
- Follicular Lymphoma (Grade 1 and 2)
- Skin Cancer Part Two
- Skin Cancer Update
- Chemotherapy Nausea and Vomiting
- An Update On CLL (Chronic Lymphocytic Leukemia)
- Cervical Cancer
- Renal Cell Cancer Therapeutic Options
- Advances In Malignant Melanoma
- To Screen Or Not To Screen? That Is The Question Part Two
- To Screen Or Not To Screen That Is The Question? Part One
- Advances In Non Small Cell Lung Cancer
- Breast Cancer Awareness
- Cancer Statistics In The United States
- Hormonal Therapy For Breast Cancer
- An Oncology Setting That Fits Your Needs Parts
- An Oncology Setting That Fits Your Needs
- Therapeutic Options For Cancer Patients In 2011
- CML A Success Story
- Malignant Melanoma
- New Therapeutic Option In CLL
- Progress Of Non Small Cell Lung Cancer
- Prostate Cancer
- The Silent Operator
- Progress In Colorectal Cancer
- Treatments For Breast Cancer
